# Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block

> **NCT02818491** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 75 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Placebo
- **DRUG:** Dexamethasone 1 mg
- **DRUG:** Dexamethasone 2 mg
- **DRUG:** Dexamethasone 3 mg
- **DRUG:** Dexamethasone 4 mg
- **DRUG:** Ropivacaine 0.5%

## Key facts

- **NCT ID:** NCT02818491
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2018-11-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2020-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02818491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02818491, "Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02818491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*